MarketBeat published consensus ratings for DiaSorin, a company headquartered in Saluggia.
5 reports, 1 independent
Updated Aug 4
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 5
- Developments
- 1
- Repetition
- 80%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat published consensus ratings for DiaSorin, a company headquartered in Saluggia.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
DiaSorin
Italian biotechnoloty company
Nothing else this week.
Related events
- MarketBeat has released its consensus rating and target price for Sunshine Biopharma, Inc.
- MarketBeat provided consensus rating data for JinkoSolar Holding Company Limited.
- MarketBeat is providing analyst ratings for Recursion Pharmaceuticals.
- MarketBeat reported the stock consensus rating for Phunware on September 8, 2026.
- MarketBeat provided consensus rating data for Nuwellis, Inc.